Sign up to save your podcasts
Or
Share New Treatment for IDH mt Gliomas
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
New Treatment for IDH mt Gliomas
Dr. Kathryn Nevel talks with Dr. Ingo Mellinghoff about how vorasidenib improved progression-free survival in patients with Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas.
Read the related article in The New England Journal of Medicine.
Visit NPUb.org/Podcast for associated article links.
View all episodes
By American Academy of Neurology
4.7
283283 ratings
Dr. Kathryn Nevel talks with Dr. Ingo Mellinghoff about how vorasidenib improved progression-free survival in patients with Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas.
Read the related article in The New England Journal of Medicine.
Visit NPUb.org/Podcast for associated article links.
More shows like Neurology® Podcast
View all
NEJM This Week
322 Listeners
JAMA Clinical Reviews
498 Listeners
Practical Neurology Podcast
51 Listeners
Mayo Clinic Talks
288 Listeners
The Curbsiders Internal Medicine Podcast
3,339 Listeners
JAMA Neurology Author Interviews
13 Listeners
Core IM | Internal Medicine Podcast
1,154 Listeners
Neurology Today in 5
22 Listeners
Annals On Call Podcast
192 Listeners
Navigating Neuropsychology
361 Listeners
The Clinical Problem Solvers
513 Listeners
Neurology Minute
133 Listeners
Neurology Exam Prep Podcast
180 Listeners
The Curious Clinicians
372 Listeners
Continuum Audio
79 Listeners